Myelodysplastic syndromes: open trials in Greece

• NCT07422480

  A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  Trial Treatment · Phase 3 · Takeda

  University General Hospital of Alexandroupoli, Alexandroupoli · Laiko General Hospital of Athens, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Ioannina, Ioannina · Hippokration Hospital, Thessaloniki

  Registry updated 2026-11-06

• NCT06788509

  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Trial Treatment · Phase 1 · Janssen Research & Development, LLC

  General Hospital of Athens - Alexandra, Athens

  Registry updated 2026-11-04

• NCT05735704

  Early Detection and Screening of Hematological Malignancies - SANGUINE

  Research · JaxBio Ltd

  National and Kapodistrian University of Athens (NKUA), Athens

  Registry updated 2026-10-15

• NCT06641414

  Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

  Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.

  University General Hospital of Alexandroupoli, Alexandroupoli · Laiko General Hospital of Athens, Athens · Evangelismos S A, Athens · Alexandra Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Olympion Therapeftirio General Clinic Of Patras S.A., Patra · University General Hospital of Thessaloniki - AHEPA, Thessaloniki

  Registry updated 2026-10-13

• NCT04064060

  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Trial Treatment · Phase 3 · Celgene

  Aghia Sophia' Children's General Hospital of Athens, Athens · Athens · Athens · Rio Patras · Thessaloniki

  Registry updated 2026-07-01

• NCT05211570

  AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  Trial Treatment · Phase 1/2 · AB Science

  “Attikon” University General Hospital of Athens, athens · Laiko General Hospital of Athens, Athens · Evaggelismos General Hospital of Athens, Athens · Universtiy General Hospital of Patra, Patra

  Registry updated 2025-10-02

• NCT05693909

  A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes

  Trial Treatment · Phase 2 · Pharmacosmos A/S

  Nosokomeio Paidon I Agia Sofia, Athens · Laiko General Hospital of Athens, Athens · Hippokration Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Ioannina, Ioannina · General Hospital Of Larissa Koutlibaneio And Triantafylleio, Larissa · Olympion Therapeftirio General Clinic Of Patras S.A., Patra · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki · Ippokratio General Hospital of Thessaloniki, Thessaloniki

  Registry updated 2025-09-24

All Myelodysplastic syndromes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error